November 22, 2019

Xcopri Approved to Treat Partial-Onset Seizures

Read More
November 22, 2019

New Oral Film Form of Riluzole Approved to Treat ALS

Read More
November 21, 2019

Calquence Receives New Indication for Chronic Lymphocytic Leukemia

Read More
November 20, 2019

Givlaari Approved to Treat Group of Rare Genetic Disorders

Read More
November 18, 2019

Abrilada Approved as Biosimilar for Humira

Read More
November 15, 2019

Adakveo Approved to Prevent Complications of Sickle Cell Disease

Read More
November 14, 2019

Brukinsa Approved to Treat Mantle Cell Lymphoma

Read More
November 14, 2019

Fetroja Approved to Treat Complicated Urinary Tract Infections

Read More
November 10, 2019

Brand Medications with Generic Alternatives Anticipated to be Approved in December

Read More
November 8, 2019

Reblozyl Approved to Treat Rare Blood Disorder

Read More
November 7, 2019

First Biosimilar for Rituxan Launched

Read More
November 5, 2019

Ziextenzo Approved as Biosimilar to Neulasta

Read More